HOME >> BIOLOGY >> NEWS
Nanotechnology's progress and challenges addressed during ACS meeting

EACH PAPER EMBARGOED FOR RELEASE UNTIL DATE AND TIME OF PRESENTATION UNLESS NOTED OTHERWISE

SAN DIEGO From promising diagnostic tests to tomorrow's electronics, nanotechnology the science and technology of the ultra-small is getting bigger all the time. More than 60 presentations, in symposia ranging from medicine to the environment to business, highlight nanotechnology's progress and challenges during the 229th national meeting of the American Chemical Society, the world's largest scientific society, in San Diego, March 13-17. Highlights from selected symposia and research presentations are highlighted below:

Monday, March 14

How do you name a nanomaterial?When the field of molecular genetics emerged, scientists often found themselves calling a new gene by different names. Nanotechnology researchers now face a similar challenge. What's more, this name game has regulatory importance: Today, the government evaluates and regulates the toxicity of a named chemical entity without considering different-sized versions of it. But nanoparticles bear unique electronic and mechanical features. Now, to clear up these concerns and more, a researcher at Rice University is leading the call to build a nomenclature for nanotechnology. (IEC 116, Monday, March 14, 4:00 p.m., Hyatt Regency, Room Ford A, during the symposium "Nanotechnology and the Environment.")

Growing the business of nanotechnology Since nanotechnology emerged, dozens of businesses in California have launched big dreams for tiny tools. Illustrating this boom is Nanosys, launched in 2002 in Palo Alto, Calif. Nanosys has built early versions of nano-enabled solar cells, flexible electronics, and nano chips for drug discovery research. Along the way, the company has formed strategic relationships with industry giants such as Intel, Dupont, In-Q-Tel, SAIC, Sharp, and Matsushita. T
'"/>


17-Mar-2005


Page: 1 2 3

Related biology news :

1. Nanotechnologys past, present and future: A Congressional perspective
2. Study begins to reveal clues to the cause and progression of sepsis
3. ACMG recognizes progress made in newborn screening
4. Neuroblastoma expert reviews progress and challenges in fighting difficult pediatric cancer
5. Scripps research scientists show protein accelerates breast cancer progression in animal models
6. Inflammation is at the origin and progression of diseases such as diabetes or cancer
7. Los Alamos National Laboratory making progress in Groundwater Protection Program
8. Crucial progress in understanding Fragile X mental retardation protein
9. Yin and yang -- Balance could play key role in progression of Alzheimers disease
10. Cancer scientists create human leukemia process to map how disease begins, progresses
11. Treatment-induced growth factor causes cancer progression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... , Jan. 25, 2016   Unisys Corporation (NYSE: ... at John F. Kennedy (JFK) International Airport, New York ... (CBP) identify imposters attempting to enter the United ... belong to them. pilot testing of the system ... at three terminals at JFK during January 2016. --> ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... FLINT, Mich. , Feb. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... as a specialty pharmacy resource–user-centric, story-driven, knowledge-based and mobile-friendly. ... ... ... "The ...
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/4/2016)... -- - New FDA action date of July ... date of July 22, 2016   --> ... 2016   - Lifitegrast has the potential ... the treatment of signs and symptoms of dry eye disease in ... be the only product approved in the U.S. in the past decade indicated for the ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
Breaking Biology Technology:
Cached News: